A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT00642018
First received: February 28, 2008
Last updated: May 24, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2012
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 24, 2012